Abstract
The serum- and glucocorticoid-regulated kinase (Sgk1) is essential for hormonal regulation of epithelial sodium channel-mediated sodium transport and is involved in the transduction of growth factor-dependent cell survival and proliferation signals. Growing evidence now points to Sgk1 as a key element in the development and/or progression of human cancer. To gain insight into the mechanisms through which Sgk1 regulates cell proliferation, we adopted a proteomic approach to identify up- or downregulated proteins after Sgk1-specific RNA silencing. Among several proteins, the abundance of which was found to be up- or downregulated upon Sgk1 silencing, we focused our attention of RAN-binding protein 1 (RANBP1), a major effector of the GTPase RAN. We report that Sgk1-dependent regulation of RANBP1 has functional consequences on both mitotic microtubule activity and taxol sensitivity of cancer cells.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Firestone GL, Giampaolo JR, O'Keeffe BA . Stimulus-dependent regulation of serum and glucocorticoid inducible protein kinase (Sgk) transcription, subcellular localization and enzymatic activity. Cell Physiol Biochem 2003; 13: 1–12.
Lang F, Böhmer C, Palmada M, Seebohm G, Strutz-Seebohm N, Vallon V . (Patho)physiological significance of the serum- and glucocorticoid-inducible kinase isoforms. Physiol Rev 2006; 86: 1151–1178.
Lang F, Perrotti N, Stournaras C . Colorectal carcinoma cells--regulation of survival and growth by Sgk1. Int J Biochem Cell Biol 2010; 42: 1571–1575.
Kobayashi T, Cohen P . Activation of serum- and glucocorticoid-regulated protein kinase by agonists that activate phosphatidylinositide 3-kinase is mediated by 3-phosphoinositidedependent protein kinase-1 (PDK1) and PDK2. Biochem J 1999; 339: 319–328.
Perrotti N, He RA, Phillips SA, Renfrew-Haft C, Taylor SI . Activation of serum and glucocorticoid- induced kinase (Sgk1) by cyclic AMP and Insulin. J Biol Chem 2001; 276: 9406–9412.
Hong F, Larrea MD, Doughty C, Kwiatkowski DJ, Squillace R, Slingerland JM . mTOR-raptor binds and activates Sgk1 to regulate p27 phosphorylation. Mol Cell 2008; 30: 701–711.
Faletti CJ, Perrotti N, Taylor SI, Blazer Yost BL . Sgk1: An essential convergence point for peptide and steroid hormone regulation of EnaC- mediated Na(+) transport. Am J Physiol 2001; 283: C494–500.
Chen SY, Bhargava A, Mastroberardino L, Meijer OC, Wang J, Buse P et al. Epithelial sodium channel regulated by aldosterone-induced protein sgk. Proc Natl Acad Sci USA 1999; 96: 2514–2519.
Alvarez de la Rosa D, Zhang P, Náray-Fejes-Tóth A, Fejes-Tóth G, Canessa CM . The serum and glucocorticoid kinase sgk increases the abundance of epithelial sodium channels in the plasma membrane of Xenopus oocytes. J Biol Chem 1999; 274: 37834–37839.
Liu D, Yang X, Songyang Z . Identification of CISK, a new member of the Sgk1 kinase family that promotes interleukin 3 dependent survival. Curr Biol 2000; 10: 1233–1236.
Leong ML, Maiyar AC, Kim B, O’Keefe BA, Firestone GL . Expression of the serum- and glucocorticoid-inducible protein kinase, Sgk1, is a cell survival response to multiple types of environmental stress stimuli in mammary epithelial cells. J Biol Chem 2003; 278: 5871–5882.
Amato R, Menniti M, Agosti V, Boito R, Costa N, Bond HM et al. IL-2 signals through Sgk1 and inhibits proliferation and apoptosis in kidney cancer cells. J Mol Med 2007; 85: 707–721.
Amato R, D'Antona L, Porciatti G, Agosti V, Menniti M, Rinaldo C et al. Sgk1 activates MDM2-dependent p53 degradation and affects cell proliferation, survival, and differentiation. J Mol Med 2009; 87: 1221–1239.
Nasir O, Wang K, Föller M, Gu S, Bhandaru M, Ackermann TF et al. Relative resistance of Sgk1 knockout mice against chemical carcinogenesis. IUBMB Life 2009; 61: 768–776.
Wang K, Gu S, Nasir O, Foller M, Ackermann TF, Klingel K et al. Sgk1-dependent intestinal tumor growth in APC-deficient mice. Cell Physiol Biochem 2010; 25: 271–278.
Hu R, Lam W, Hsu CH, Cheng YC . UMP/CMPK is not the critical enzyme in the metabolism of pyrimidine ribonucleotide and activation of deoxycytidine analogs in human RKO cells. PLoS One 2011; 6: e19490.
Zhang Y, Bao YL, Yang MT, Wu Y, Yu CL, Huang YX et al. Activin A induces SLC5A8 expression through the Smad3 signaling pathway in human colon cancer RKO cells. Int J Biochem Cell Biol 2010; 42: 1964–1972.
Guarguaglini G, Renzi L, D'Ottavio F, Di Fiore B, Casenghi M, Cundari E et al. Regulated Ran-binding protein 1 activity is required for organization and function of the mitotic spindle in mammalian cells in vivo. Cell Growth Differ 2000; 11: 455–465.
Di Fiore B, Ciciarello M, Mangiacasale R, Palena A, Tassin AM, Cundari E, Lavia P . Mammalian RanBP1 regulates centrosome cohesion during mitosis. J Cell Sci 2003; 116: 3399–3411.
Peloponese JM, Haller K, Miyazato A, Jeang KT . Abnormal centrosome amplification in cells through the targeting of Ran-binding protein-1 by the human T cell leukemia virus type-1 Tax oncoprotein. Proc Natl Acad Sci USA 2005; 102: 18974–9.
Li HY, Ng WP, Wong CH, Iglesias PA, Zheng Y . Coordination of chromosome alignment and mitotic progression by the chromosome-based Ran signal. Cell Cycle 2007; 6: 1886–1895.
Tedeschi A, Ciciarello M, Mangiacasale R, Roscioli E, Rensen WM, Lavia P . RANBP1 localizes a subset of mitotic regulatory factors on spindle microtubules and regulates chromosome segregation in human cells. J Cell Sci 2007; 120: 3748–3761.
Ciciarello M, Mangiacasale R, Lavia P . Spatial control of mitosis by the GTPase Ran. Cell Mol Life Sci 2007; 64: 891–914.
Kalab P, Heald R . The RanGTP gradient - a GPS for the mitotic spindle. J Cell Sci 2008; 121: 1577–1586.
Yuen HF, Chan KK, Grills C, Murray JT, Platt-Higgins AM, Sharaf Eldin O et al. Ran is a potential therapeutic target for cancer cells with molecular changes associated with activation of the PI3K/Akt/mTORC1 and Ras/MEK/ERK pathways. Clin Cancer Res Clin Cancer Res 2012; 18: 380–91.
McCaig C, Potter L, Abramczyk O, Murray JT . Phosphorylation of NDRG1 is temporally and spatially controlled during the cell cycle. Biochem Biophys Res Commun 2011; 411: 227–234.
Gaspari M, Abbonante V, Cuda G . Gel-free sample preparation for the nanoscale LC-MS/MS analysis and identification of low-nanogram protein samples. Science 2007; 30: 2210–2216.
Menniti M, Iuliano R, Amato R, Boito R, Corea M, Le Pera I et al. Serum and glucocorticoid-regulated kinase Sgk1 inhibits insulin-dependent activation of phosphomannomutase 2 in transfected COS-7 cells. Am J Physiol Cell Physiol 2005; 288: C148–55.
Menniti M, Iuliano R, Föller M, Sopjani M, Alesutan I, Mariggiò S et al. 60kDa lysophospholipase, a new Sgk1 molecular partner involved in the regulation of ENaC. Cell Physiol Biochem 2010; 26: 587–596.
Hardy S, Kitamura M, Harris-Stansil T, Dai Y, Phipps ML . Construction of Adenovirus vectors through Cre-lox recombination. J Virol 1997; 7: 1842–1849.
Di Fiore B, Guarguaglini G, Palena A, Kerkhoven RM, Bernards R, Lavia P . Two E2F sites control growth-regulated and cell cycle-regulated transcription of the Htf9-a/RanBP1 gene through functionally distinct mechanisms. J Biol Chem 1999; 274: 10339–10348.
Gorman CM, Moffat LF, Howard BH . Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol Cell Biol 1982; 2: 1044–1051.
Faniello MC, Di Sanzo M, Quaresima B, Baudi F, Di Caro V, Cuda G et al. p53-mediated downregulation of HOURS ferritin promoter transcriptional efficiency via NF-Y. Int J Biochem Cell Biol 2008; 40: 2110–2119.
Tan NY, Khachigian LM . Sp1 phosphorylation and its regulation of gene transcription. Mol Cell Biol 2009; 29: 2483–2488.
Kim HS, Lim IK . Phosphorylated extracellular signal-regulated protein kinases 1 and 2 phosphorylate sp1 on serine 59 and regulate cellular senescence via transcription of p21Sdi1/Cip1/Waf1. J Biol Chem 2009; 284: 15475–15486.
Rensen WM, Roscioli E, Tedeschi A, Mangiacasale R, Ciciarello M, Di Gioia SA et al. RanBP1 downregulation sensitizes cancer cells to taxol in a caspase-3-dependent manner. Oncogene 2009; 28: 1748–1758.
Bischoff FR, Krebber HOURS, Smirnova E, Dong W, Ponstingl HOURS . Co-activation of RanGTPase and inhibition of GTP dissociation by Ran-GTP binding protein RanBP1. EMBO J 1995; 14: 705–715.
Plafker K, Macara IG . Fluorescence resonance energy transfer biosensors that detect Ran conformational changes and a Ran x GDP-importin-beta -RanBP1 complex in vitro and in intact cells. J Biol Chem 2002; 277: 30121–30127.
Clarke PR, Zhang C . Spatial and temporal coordination of mitosis by Ran GTPase. Nat Rev Mol Cell Biol 2008; 9: 464–477.
Archer MC . Role of Sp transcription factors in the regulation of cancer. Cell Metabol Genes Cancer 2011; 2: 712–719.
Yamada HY, Rao CV . Genes that modulate the sensitivity for anti-microtubule drug-mediated chemotherapy. Curr Cancer Drug Targets 2010; 10: 623–33.
Feng Z, Liu L, Zhang C, Zheng T, Wang J, Lin M et al. Chronic restraint stress attenuates p53 function and promotes tumorigenesis. Proc Natl Acad Sci USA 109: 7013–8.
Acknowledgements
This work was supported in part by the Italian Association for Cancer Research (AIRC grant IG10164 to PL). RA was supported in part by INAIL, CZ.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies the paper on the Oncogene website
Supplementary information
Rights and permissions
About this article
Cite this article
Amato, R., Scumaci, D., D'Antona, L. et al. Sgk1 enhances RANBP1 transcript levels and decreases taxol sensitivity in RKO colon carcinoma cells. Oncogene 32, 4572–4578 (2013). https://doi.org/10.1038/onc.2012.470
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/onc.2012.470
Keywords
This article is cited by
-
Predicting chemosensitivity using drug perturbed gene dynamics
BMC Bioinformatics (2021)
-
Drug repurposing against COVID-19: focus on anticancer agents
Journal of Experimental & Clinical Cancer Research (2020)
-
Integrated nomogram based on five stage-related genes and TNM stage to predict 1-year recurrence in hepatocellular carcinoma
Cancer Cell International (2020)
-
Identification, structure modification, and characterization of potential small-molecule SGK3 inhibitors with novel scaffolds
Acta Pharmacologica Sinica (2018)
-
SGK1 affects RAN/RANBP1/RANGAP1 via SP1 to play a critical role in pre-miRNA nuclear export: a new route of epigenomic regulation
Scientific Reports (2017)